Blue Jet Healthcare profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026
Margins
30.6%
35.6%
26.5%
Additional
25.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BLUEJET₹503.55

Blue Jet Healthcare Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABAARTIPHARMCAPLIPOINTACUTAASCONCORDBIOEMCUREERISGRANULES
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
Last 12M
30/06/2026
Margins
EBITDA Margin——30.62
Pretax Margin——35.63
Net Income Margin——26.52
Additional
Effective Tax Rate——25.57
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 97%.